Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$14.51 - $20.99 $77,686 - $112,380
5,354 New
5,354 $77,000
Q1 2021

May 14, 2021

SELL
$19.92 - $31.6 $298 - $474
-15 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$10.69 - $16.49 $769 - $1,187
-72 Reduced 82.76%
15 $0
Q1 2020

Jun 11, 2020

BUY
$9.78 - $29.53 $704 - $2,126
72 Added 480.0%
87 $1,000
Q1 2020

May 07, 2020

BUY
$9.78 - $29.53 $146 - $442
15 New
15 $215,000
Q2 2019

Aug 14, 2019

SELL
$22.67 - $35.0 $2,017 - $3,115
-89 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$27.23 - $45.56 $2,423 - $4,054
89 New
89 $3,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.17B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.